AndroGel 1.62% is a specific prescription testosterone gel with a defined formulation and detailed directions. Those details matter when a clinician discusses a topical option: another strength, another brand, or a compounded cream may have different instructions even when the ingredient is testosterone.
We checked the current U.S. prescribing label and FDA compounding guidance on September 21, 2026. This article explains what to ask your clinician and pharmacist. It does not select a dose, confirm insurance coverage, or establish that every reviewed TRT clinic offers this product.
- Check the precise strength and container at each prescription change.
- Household-contact precautions are part of using the product.
- Ask for product-specific testing and monitoring instructions.
Is this the exact product on my prescription?
Check the full name, strength, packaging, and dispensing label with the pharmacist. AndroGel 1.62% has directions that differ from AndroGel 1%. A compounded cream is another preparation again and does not have FDA approval simply because an approved gel contains the same hormone.
Ask why the clinician recommends this particular formulation and whether other approved options are appropriate. The medication-names guide can help you distinguish an ingredient, brand, and dosage form. Similar names are not enough to justify transferring instructions between products.
Where and how should this gel be applied?
The 1.62% label specifies the shoulders and upper arms as application sites. Other sites used for other testosterone preparations should not be assumed appropriate. Ask for a demonstration of the prescribed pump or packet and make sure you understand the directions for that exact container.
Avoid translating another person’s pump count or a previous cream quantity into a new dose. If the packaging changes at a refill, ask the pharmacist to explain what is the same and what differs. Clear instructions help prevent a product change from becoming an unintended change in treatment.
How do I protect people around me?
The product has a boxed warning about secondary testosterone exposure, including effects in children. Its handling instructions address washing hands, letting the gel dry, covering treated skin, and washing the application area before expected skin contact with another person. Discuss the full directions with the pharmacist.
Think about your actual household routine, including close contact with a partner or children. If accidental contact occurs, use the product’s instructions and seek appropriate clinical advice. Our household-safety guide discusses why another person’s exposure needs attention rather than reassurance based only on the gel being dry.
How does bathing fit around application?
The AndroGel 1.62% instructions specify a minimum period before swimming, showering, or washing the application area. The label also warns that the alcohol-containing gel is flammable until dry. These are practical requirements to understand before deciding the routine fits your morning.
Ask the pharmacist to explain the complete timing and handling directions rather than relying on a short online summary. A different topical product can have different requirements. If daily care, work, or household contact makes the routine difficult, discuss that with the prescriber before altering the application plan.
When should my blood sample be taken?
The label specifies how testosterone testing is used to assess and adjust the prescribed treatment. Ask the clinic for instructions on sample timing relative to your application. Results need the context of the exact product and routine, especially when you transfer care or change formulations.
Keep that information with your test date and medication list. The free testosterone and SHBG guide explains why different laboratory measurements answer different questions. Do not change the dose yourself after seeing a portal result without the prescriber’s interpretation.
Which risks and goals will we review?
The gel’s label includes blood-pressure increases, blood-count changes, clotting and prostate-related concerns, fertility effects, and other precautions. Safety and effectiveness for age-related hypogonadism have not been established. The convenience of a topical route does not replace a confirmed diagnosis and individualized discussion of risks.
Ask how the team will assess your symptoms and decide whether treatment remains worthwhile. Our treatment-goals guide helps frame that discussion. If a nasal alternative comes up, the Natesto questions page describes a different routine with its own precautions; it is not a substitution guide.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked September 21, 2026. Article updated September 21, 2026.